Home › Entities › clinical_trial › Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

clinical trial
MedicalStudy clinical_trial Q90693591
Press Enter · cited answer in seconds

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Summary

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers is a clinical trial[1].

Key Facts

  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers is in the country of United States[2].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's instance of is recorded as clinical trial[3].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's start time is recorded as +2020-04-03T00:00:00Z[4].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's end time is recorded as +2020-11-30T00:00:00Z[5].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's main subject is recorded as DNA vaccine[6].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's main subject is recorded as INO-4800[7].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's main subject is recorded as COVID-19[8].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's number of participants is recorded as {'unit': '1', 'amount': '+40'}[9].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's title is recorded as Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers[10].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's ClinicalTrials.gov ID is recorded as NCT04336410[12].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[13].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's research intervention is recorded as INO-4800[14].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's clinical trial phase is recorded as phase I clinical trial[15].
  • Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers's study type is recorded as interventional study[16].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers. Retrieved May 3, 2026, from https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers
MLA “Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers.
BibTeX @misc{4ortxyz_safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers}}, year = {2026}, url = {https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers — https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-for-covid-19-in-healthy-volunteers · Last refreshed: